This book is a unique compendium of the major studies of aging and schizophrenia. In this way, it provides an essential resource for current understanding of the issues involved. The effort itself ...

This book will also serve as an excellent resource for psychiatrists, psychiatric nurses, psychologists, social workers, GPs and students who should find the book relevant both for their own practice ...

Symptoms of schizophrenia, a serious mental disorder that can include hallucinations and delusions, vary greatly from person to person. One common group of schizophrenia symptoms that doesn’t ...

I have schizoaffective disorder, bipolar type — a combination of schizophrenia and bipolar disorder — and I agree that this is a monumental development for my community. Historically ...

When you purchase an independently reviewed book through our site ... s descent into what would eventually be diagnosed as schizophrenia, while also exploring the through-line of mental illness ...

Auditory verbal hallucinations are one of the hallmarks of psychosis, particularly in people with schizophrenia, which affects 24 million people globally. These voices often bully or abuse the ...

It hasn’t been an easy road for Joey Wilson. He says he’s dealt with the odds being against him since he was born prematurely ...

Hi. I'm Michele Hammer and I have schizophrenia. Schizophrenia is a mental illness that changes the way you think, feel, and act. It's broken down into three separate categories, positive ...

About one in 300 people worldwide are affected by schizophrenia, but for decades treatment options have been both static and limited. If the FDA approves the twice-daily pill on Thursday ...

Caplyta (lumateperone) was approved for the treatment of schizophrenia in 2019 and for depressive episodes linked to bipolar I or bipolar II disorder (bipolar depression) in 2021. Caplyta can be ...

The National Institute of Mental Health defines schizophrenia as a "severe and disabling" condition characterized by "hallucinations, delusions, and thought disorder." Around 2.8 million American ...

The double-blind, placebo-controlled trial involved 182 adults with a confirmed diagnosis of schizophrenia who were randomised 1:1 to receive a twice-daily, flexible dose of KarXT or placebo for ...